XML 79 R73.htm IDEA: XBRL DOCUMENT v3.25.3
Segments - Schedule of Revenues by Major Products and Activities (Detail) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Product Information [Line Items]        
Revenues $ 4,480 $ 4,332 $ 12,547 $ 12,315
United States [Member]        
Product Information [Line Items]        
Revenues 2,483 2,225 6,543 6,060
Europe [Member]        
Product Information [Line Items]        
Revenues 1,235 1,265 3,726 3,749
International Markets [Member]        
Product Information [Line Items]        
Revenues 557 613 1,634 1,802
Generic products (including OTC and biosimilars) [Member] | United States [Member]        
Product Information [Line Items]        
Revenues 1,175 1,094 2,984 2,924
Generic products (including OTC and biosimilars) [Member] | Europe [Member]        
Product Information [Line Items]        
Revenues 982 973 3,011 2,947
Generic products (including OTC and biosimilars) [Member] | International Markets [Member]        
Product Information [Line Items]        
Revenues 421 477 1,298 1,440
AJOVY [Member] | United States [Member]        
Product Information [Line Items]        
Revenues 73 58 190 144
AJOVY [Member] | Europe [Member]        
Product Information [Line Items]        
Revenues 66 56 195 158
AJOVY [Member] | International Markets [Member]        
Product Information [Line Items]        
Revenues 30 24 78 63
AUSTEDO [Member] | United States [Member]        
Product Information [Line Items]        
Revenues 601 435 1,492 1,124
AUSTEDO [Member] | International Markets [Member]        
Product Information [Line Items]        
Revenues 17 13 34 39
BENDEKA and TREANDA [Member] | United States [Member]        
Product Information [Line Items]        
Revenues 35 40 111 127
COPAXONE [Member] | United States [Member]        
Product Information [Line Items]        
Revenues 62 69 179 179
COPAXONE [Member] | Europe [Member]        
Product Information [Line Items]        
Revenues 44 53 135 163
COPAXONE [Member] | International Markets [Member]        
Product Information [Line Items]        
Revenues 8 13 25 38
UZEDY [Member] | United States [Member]        
Product Information [Line Items]        
Revenues 43 35 136 75
Anda [Member] | United States [Member]        
Product Information [Line Items]        
Revenues 392 380 1,130 1,134
Respiratory Product [Member] | Europe [Member]        
Product Information [Line Items]        
Revenues 52 60 162 183
Other [Member] | United States [Member]        
Product Information [Line Items]        
Revenues 101 115 321 352
Other [Member] | Europe [Member]        
Product Information [Line Items]        
Revenues 91 [1] 124 [1] 223 [2] 299 [2]
Other [Member] | International Markets [Member]        
Product Information [Line Items]        
Revenues $ 82 [1] $ 86 [1] $ 199 [2] $ 222 [2]
[1] Other revenues in the third quarter of 2025 and 2024 include the sale of certain product rights.
[2] Other revenues in the first nine months of 2025 and 2024 include the sale of certain product rights.